Stock DNA
Software Products
USD 2,191 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.55
-999,999.00%
1.80
Revenue and Profits:
Net Sales:
178 Million
(Quarterly Results - Jan 2026)
Net Profit:
-73 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
96.64%
0%
96.64%
6 Months
32.89%
0%
32.89%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Navan, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
33.50%
EBIT Growth (5y)
56.30%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.80
EV to EBIT
-10.82
EV to EBITDA
-11.63
EV to Capital Employed
2.78
EV to Sales
2.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-25.72%
ROE (Latest)
-17.62%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bullish
OBV
Mildly Bearish
Shareholding Snapshot : Jan 2026
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 23 Schemes (6.96%)
Foreign Institutions
Held by 39 Foreign Institutions (5.07%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jan'26 - QoQ
Jan'26
Oct'25
Change(%)
Net Sales
177.90
194.90
-8.72%
Operating Profit (PBDIT) excl Other Income
-26.30
-73.30
64.12%
Interest
3.80
15.50
-75.48%
Exceptional Items
-6.70
-126.60
94.71%
Consolidate Net Profit
-72.80
-225.40
67.70%
Operating Profit Margin (Excl OI)
-465.40%
-406.50%
-5.89%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jan 2026 is -8.72% vs 13.31% in Oct 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jan 2026 is 67.70% vs -483.94% in Oct 2025
Annual Results Snapshot (Consolidated) - Jan'26
Jan'26
Jan'25
Change(%)
Net Sales
702.30
536.80
30.83%
Operating Profit (PBDIT) excl Other Income
-129.90
-82.70
-57.07%
Interest
51.30
76.00
-32.50%
Exceptional Items
-174.60
12.20
-1,531.15%
Consolidate Net Profit
-398.00
-181.10
-119.77%
Operating Profit Margin (Excl OI)
-270.80%
-200.50%
-7.03%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2026 is 30.83% vs 33.43% in Jan 2025
Consolidated Net Profit
YoY Growth in year ended Jan 2026 is -119.77% vs 45.39% in Jan 2025






